Infectologia

Nova diretriz provisória do CDC recomenda um regime de 4 meses de rifapentina-moxifloxacino para tratamento da tuberculose pulmonar não resistente.

28 Fev, 2022 | 13:41h

Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis — United States, 2022 – CDC Morbidity and Mortality Weekly Report

Conteúdos relacionados:

Summary | WHO recommendations on the treatment of drug-resistant tuberculosis, 2020 update.

WHO Guideline: Screening for Tuberculosis Disease

New WHO Recommendations to Prevent Tuberculosis

CDC Guidelines for the Treatment of Latent Tuberculosis Infection

Guideline: Treatment of Drug-Resistant Tuberculosis

NICE Guideline: Tuberculosis

The Lancet Commission: Management of Multidrug-resistant and Incurable Tuberculosis

Regimens to Treat Multidrug-resistant Tuberculosis: Past, Present and Future Perspectives

Guidelines for the Management of TB in Adults Living with HIV

 

Comentário no Twitter

Clinicians: @CDC_TB released interim guidance on a new regimen to treat #TB disease. Learn more about the 4-month regimen containing rifapentine, moxifloxacin, isoniazid, and pyrazinamide for people with drug-susceptible pulmonary TB disease in the U.S.: https://t.co/eOcR34tYJu pic.twitter.com/EFGMwAwN7c

— MMWR (@CDCMMWR) February 25, 2022

 

---

Diretrizes ESCMID COVID-19: testes diagnósticos para SARS-CoV-2.

28 Fev, 2022 | 13:39h

ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2 – Clinical Microbiology and Infection

---

CDC emite nova diretriz muito aguardada sobre quando usar máscaras.

28 Fev, 2022 | 13:38h

CDC issues long-awaited new guidance on when to wear masks – STAT

Ver também: As mask mandates fade, experts say use of masks likely will not – STAT

---

Consenso sobre aspectos técnicos/cirúrgicos intraoperatórios para prevenir infecção de sítio cirúrgico após cirurgia colorretal.

28 Fev, 2022 | 13:33h

Delphi Consensus on Intraoperative Technical/Surgical Aspects to Prevent Surgical Site Infection after Colorectal Surgery – Journal of the American College of Surgeons

---

Diretriz de consenso | Implementação bem-sucedida da saúde digital como garantia de segurança de saúde global durante pandemias futuras.

25 Fev, 2022 | 14:26h

Successfully Implementing Digital Health to Ensure Future Global Health Security During Pandemics: A Consensus Statement – JAMA Network Open

---

Números atualizados sugerem que pelo menos 5 milhões de crianças perderam um dos pais ou um cuidador para a COVID-19 desde março de 2020.

25 Fev, 2022 | 14:24h

Comunicado de imprensa:  At least 5 million children have lost a parent or caregiver due to COVID-19 since March 2020, updated figures suggest – The Lancet

Estudo original: Global, regional, and national minimum estimates of children affected by COVID-19-associated orphanhood and caregiver death, by age and family circumstance up to Oct 31, 2021: an updated modelling study – The Lancet Child & Adolescent Health

Comentários:

Integrative approaches required to support children affected by COVID-19 – The Lancet Child & Adolescent Health

Millions of children worldwide have lost a parent or caregiver to COVID-19: “The hidden pandemic” – CBS News

Conteúdos relacionados:

More than 1.5 million children lost a primary or secondary caregiver due to the COVID-19 pandemic.

Covid-19 Has Created Thousands Of Newly Single Parents And Orphans

 

Comentário no Twitter (fio – clique para saber mais)

At least 5 million children have lost a parent or caregiver due to #COVID19 since March 2020, updated figures suggest.

Authors urge actions to prioritise affected children, incl. economic strengthening, enhanced community & family support, & education. https://t.co/1slpFhjDJd pic.twitter.com/AvEncg4Yx1

— The Lancet (@TheLancet) February 24, 2022

 

---

Estudo sugere que a síndrome inflamatória multissistêmica em crianças (MIS-C) é rara entre adolescentes vacinados.

25 Fev, 2022 | 14:22h

Reported cases of multisystem inflammatory syndrome in children aged 12–20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation – The Lancet Child & Adolescent Health

Comentários:

When vaccine adverse event reporting generates hope, not fear – The Lancet Child & Adolescent Health

MIS-C rare in COVID-vaccinated teens, study finds – CIDRAP

Vaccination Greatly Reduces Odds of MIS-C in Teens Who Get COVID – HealthDay

 

Comentário no Twitter

New study from @CDCgov finds that multi-system inflammatory syndrome in children (#MISC) is rare among 12 to 20-year-olds who have received #COVID19 vaccination (1.0 case per million individuals receiving one or more doses)https://t.co/BpsXSpMMcH

— The Lancet Child & Adolescent Health (@LancetChildAdol) February 23, 2022

 

---

Imunidade prévia da população e gravidade da Covid-19 com a variante Ômicron na África do Sul.

24 Fev, 2022 | 15:52h

Population Immunity and Covid-19 Severity with Omicron Variant in South Africa – New England Journal of Medicine

Entrevista em áudio: Understanding the Omicron Variant of SARS-CoV-2

 

Comentário no Twitter

In Gauteng, South Africa, where the omicron variant was first identified, two thirds of unvaccinated residents were seropositive for SARS-CoV-2, which indicates past infection. Omicron peaked just 1 month after being detected. #COVID19 https://t.co/Z8qTI1DNkv pic.twitter.com/ZZv2xevacG

— NEJM (@NEJM) February 23, 2022

 

---

Editorial | Mirando na inequidade vacinal – Vacinas contra Covid-19 como um bem público global.

24 Fev, 2022 | 15:51h

Addressing Vaccine Inequity — Covid-19 Vaccines as a Global Public Good – New England Journal of Medicine

---

[Preprint] Quarta dose da vacina contra COVID fornece somente um leve reforço contra a infecção pela variante Ômicron.

24 Fev, 2022 | 15:50h

Fourth dose of COVID vaccine offers only slight boost against Omicron infection – Nature

Estudo original: 4th Dose COVID mRNA Vaccines’ Immunogenicity & Efficacy Against Omicron VOC – medRxiv

---